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Introduction
Glycogen storage diseases, the commonest of which is
Von Gierke disease, are characterized by excessive
deposit of glycogen in liver and muscle owing to the
lack of key enzymes in glycogen metabolism.
Objectives
The occurrence of gout in patients with Von Gierke dis-
ease may be related to acidosis causing a decrease in
uric acid excretion by the proximal tubule and routing
of glucose-6-phosphate to the pentose pathway.
Results
A 7 year-old girl was admitted to out patient clinic with
a swollen and painful toe associated with lethargy and
poor appetite; there was no rash, serositis, or eye inflam-
mation, no muscle pain or weakness. Her history
revealed that she had been followed up with a diagnosis
of glycogen storage disease type 1 and neutropenia since
she was 1 year-old. She had recurrent attacks of pain
and edema in her toes, ankles and hip which lasts for a
while and resolved sometimes by itself sometimes by
non-steroidal anti-inflammatory drugs. Physical exami-
nation revealed marked edema, induration and pain in
the first toe of right foot as well as hepatomegaly.
Serum investigations revealed iron deficiency, neutro-
penia, elevated erythrocyte sedimentation rate, c-reactive
protein and fibrinogen levels. Serum uric acid, lactate,
and fasting triglycerides were elevated as well. MEFV
mutation analysis was negative. She was given colchi-
cines for her gout, allopurinol for high serum uric acid
levels and diet counseling to help regulate his blood glu-
cose through the day. She was followed up for 4 years
with colchicines with only few attacks of gouty arthritis.
Conclusion
Colchicine could be the drug of choice in the treatment
of gouty arthritis with life style management and appro-
priate diet. Though liver transplantation would be the
definitive treatment for glycogen storage disease, its
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